Institute of Clinical and Molecular Virology

Symptoms, SARS-CoV-2 Antibodies, and Neutralization Capacity in a Cross Sectional-Population of German Children (2021) Laub O, Leipold G, Toncheva AA, Peterhoff D, Einhauser S, Neckermann P, Borchers N, et al. Journal article IMU-838, a small molecule DHODH inhibitor in phase II clinical trial for multiple sclerosis, shows potent Anti-EBV activity in cell-culture-based systems: Potential additional benefits in multiple sclerosis treatment (2021) Marschall M, Peelen E, Müller R, Wangen C, Wagner S, Muehler A, Groeppel M, et al. Conference contribution Artificial intelligence-based 3D angiography for visualization of complex cerebrovascular pathologies (2021) Lang S, Hölter P, Schmidt M, Strother C, Kaethner C, Kowarschik M, Dörfler A Journal article Spectrum bias and individual strengths of SARS-CoV-2 serological tests–A population-based evaluation (2021) Einhauser S, Peterhoff D, Niller HH, Beileke S, Günther F, Steininger P, Burkhardt R, et al. Journal article Reactogenicity correlates only weakly with humoral immunogenicity after COVID-19 vaccination with BNT162b2 mRNA (Comirnaty®) (2021) Held J, Esse J, Tascilar K, Steininger P, Schober K, Irrgang P, Alsalameh R, et al. Journal article Cloning of a passage-free SARS-CoV-2 genome and mutagenesis using red recombination (2021) Herrmann A, Jungnickl D, Cordsmeier A, Peter AS, Überla K, Enßer A Journal article Lectin from triticum vulgaris (WGA) inhibits infection with SARS-CoV-2 and its variants of concern alpha and beta (2021) Auth J, Fröba M, Große M, Rauch P, Ruetalo N, Schindler M, Morokutti-kurz M, et al. Journal article A Barcoded Flow Cytometric Assay to Explore the Antibody Responses Against SARS-CoV-2 Spike and Its Variants (2021) Vesper N, Ortiz Y, Bartels-Burgahn F, Yang J, De La Rosa K, Tenbusch M, Schulz S, et al. Journal article Respiratory syncytial-virus induced cytokine production from leukocytes is impaired in severe asthma (2021) Jameel KJ, Yanik S, Buelthoff E, Rohde S, Weidinger D, Yusuf F, Kronsbein J, et al. Conference contribution Successful treatment of COVID-19 with convalescent plasma in B-cell depleted patients may promote cellular immunity (2021) Kremer A, Kremer A, Willam C, Verhagen J, Achenbach S, Van Der Meiden E, Lang V, et al. Conference contribution